Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5631]

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced...

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers

ASCO 2019: Adding ribociclib to first-line endocrine therapy significantly improves survival for pre-menopausal women with advanced breast cancer

ASCO 2019: Adding ribociclib to first-line endocrine therapy significantly improves survival for pre-menopausal...

Interaction with stromal cells influences tumour growth and metastasis in pancreatic cancer

Interaction with stromal cells influences tumour growth and metastasis in pancreatic cancer

Towards a safer treatment for leukaemia

Towards a safer treatment for leukaemia

De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

FDA approves avelumab plus axitinib for renal cell carcinoma

FDA approves avelumab plus axitinib for renal cell carcinoma

FDA approves venetoclax for chronic lymphocytic leukaemia and small lymphocytic lymphoma

FDA approves venetoclax for chronic lymphocytic leukaemia and small lymphocytic lymphoma

How molecular escorts help prevent cancer

How molecular escorts help prevent cancer

More from ecancer